Annual Total Liabilities
$14.21 M
-$1.29 M-8.30%
December 31, 2023
Summary
- As of February 6, 2025, LRMR annual total liabilities is $14.21 million, with the most recent change of -$1.29 million (-8.30%) on December 31, 2023.
- During the last 3 years, LRMR annual total liabilities has fallen by -$779.00 thousand (-5.20%).
- LRMR annual total liabilities is now -8.30% below its all-time high of $15.50 million, reached on December 31, 2022.
Performance
LRMR Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$20.62 M
-$5.14 M-19.94%
September 30, 2024
Summary
- As of February 6, 2025, LRMR quarterly total liabilities is $20.62 million, with the most recent change of -$5.14 million (-19.94%) on September 30, 2024.
- Over the past year, LRMR quarterly total liabilities has dropped by -$5.14 million (-19.94%).
- LRMR quarterly total liabilities is now -19.94% below its all-time high of $25.76 million, reached on June 30, 2024.
Performance
LRMR Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
LRMR Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.3% | -19.9% |
| 3 y3 years | -5.2% | -19.9% |
| 5 y5 years | +141.1% | -19.9% |
LRMR Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.3% | at low | -19.9% | +83.5% |
| 5 y | 5-year | -8.3% | +141.1% | -19.9% | +249.8% |
| alltime | all time | -8.3% | +141.1% | -19.9% | +249.8% |
Larimar Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $20.62 M(-19.9%) |
| Jun 2024 | - | $25.76 M(+48.4%) |
| Mar 2024 | - | $17.36 M(+22.1%) |
| Dec 2023 | $14.21 M(-8.3%) | $14.21 M(+26.5%) |
| Sep 2023 | - | $11.24 M(-4.6%) |
| Jun 2023 | - | $11.79 M(-6.9%) |
| Mar 2023 | - | $12.67 M(-18.3%) |
| Dec 2022 | $15.50 M | $15.50 M(+8.0%) |
| Sep 2022 | - | $14.35 M(+12.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $12.80 M(-9.4%) |
| Mar 2022 | - | $14.12 M(-1.0%) |
| Dec 2021 | $14.25 M(-4.9%) | $14.25 M(-10.2%) |
| Sep 2021 | - | $15.87 M(+18.4%) |
| Jun 2021 | - | $13.41 M(-5.8%) |
| Mar 2021 | - | $14.23 M(-5.1%) |
| Dec 2020 | $14.99 M(+154.4%) | $14.99 M(+32.5%) |
| Sep 2020 | - | $11.32 M(-12.4%) |
| Jun 2020 | - | $12.91 M(+119.1%) |
| Dec 2019 | $5.89 M | $5.89 M |
FAQ
- What is Larimar Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Larimar Therapeutics?
- What is Larimar Therapeutics annual total liabilities year-on-year change?
- What is Larimar Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Larimar Therapeutics?
- What is Larimar Therapeutics quarterly total liabilities year-on-year change?
What is Larimar Therapeutics annual total liabilities?
The current annual total liabilities of LRMR is $14.21 M
What is the all time high annual total liabilities for Larimar Therapeutics?
Larimar Therapeutics all-time high annual total liabilities is $15.50 M
What is Larimar Therapeutics annual total liabilities year-on-year change?
Over the past year, LRMR annual total liabilities has changed by -$1.29 M (-8.30%)
What is Larimar Therapeutics quarterly total liabilities?
The current quarterly total liabilities of LRMR is $20.62 M
What is the all time high quarterly total liabilities for Larimar Therapeutics?
Larimar Therapeutics all-time high quarterly total liabilities is $25.76 M
What is Larimar Therapeutics quarterly total liabilities year-on-year change?
Over the past year, LRMR quarterly total liabilities has changed by -$5.14 M (-19.94%)